Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 9.50
+0.50 (5.56%)
Apr 17, 2026, 8:16 AM GMT
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 39.01 million as of April 16, 2026. Its market cap has increased by 59.62% in one year.
Market Cap
39.01M
Enterprise Value
36.25M
Revenue
9.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.50
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 39.01M, a decrease of -61.37%. That is a compound annual growth rate of -16.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 37.92M | 36.72% |
| Dec 31, 2025 | 27.74M | -7.08% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.38B |
| GSK plc | 87.49B |
| Haleon | 31.84B |
| Smith & Nephew | 10.79B |
| Faron Pharmaceuticals Oy | 51.41M |
| Kooth | 50.05M |
| Creo Medical Group | 47.29M |
| BATM Advanced Communications | 43.19M |